Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists
- 15 February 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (4), 1197-1200
- https://doi.org/10.1016/j.bmcl.2004.11.078
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Anxiolytic-like activity of the mGluR5 antagonist MPEP: A comparison with diazepam and buspironePharmacology Biochemistry and Behavior, 2002
- The metabotropic glutamate receptors: structure, activation mechanism and pharmacology.Current Drug Targets-CNS & Neurological Disorders, 2002
- Metabotropic Glutamate Receptor Involvement in Models of Acute and Persistent Pain: Prospects for the Development of Novel AnalgesicsCurrent Drug Targets-CNS & Neurological Disorders, 2002
- Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608)European Journal of Pharmacology, 2001
- Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant miceNature Neuroscience, 2001
- The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in ratsNeuropharmacology, 2001
- Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonistBritish Journal of Pharmacology, 2001
- Ligands for Glutamate Receptors: Design and Therapeutic ProspectsJournal of Medicinal Chemistry, 2000
- Glutamate receptors in the mammalian central nervous systemProgress in Neurobiology, 1998
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997